Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 8 » default
Diabetes, Metabolic Syndrome and Obesity
ISSN: 1178-7007
- View all (2603)
- Volume 17, 2024 (158)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Archive: Volume 8, 2015
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
Cebeci Z, Kir N
Diabetes, Metabolic Syndrome and Obesity 2015, 8:555-566
Published Date: 16 November 2015
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
Seufert J
Diabetes, Metabolic Syndrome and Obesity 2015, 8:543-554
Published Date: 9 November 2015
Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity 2015, 8:535-542
Published Date: 30 October 2015
Red cell distribution width in type 2 diabetic patients
Nada AM
Diabetes, Metabolic Syndrome and Obesity 2015, 8:525-533
Published Date: 30 October 2015
Specific cut-off points for waist circumference and waist-to-height ratio as predictors of cardiometabolic risk in Black subjects: a cross-sectional study in Benin and Haiti
EL Mabchour A, Delisle H, Vilgrain C, Larco P, Sodjinou R, Batal M
Diabetes, Metabolic Syndrome and Obesity 2015, 8:513-523
Published Date: 23 October 2015
Emerging utility of once-weekly exenatide in patients with type 2 diabetes
Goud A, Zhong J, Rajagopalan S
Diabetes, Metabolic Syndrome and Obesity 2015, 8:505-512
Published Date: 21 October 2015
Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks
Nikokavoura EA, Johnston KL, Broom J, Wrieden WL, Rolland C
Diabetes, Metabolic Syndrome and Obesity 2015, 8:495-503
Published Date: 14 October 2015
Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
Thuillier P, Alavi Z, Kerlan V
Diabetes, Metabolic Syndrome and Obesity 2015, 8:483-493
Published Date: 1 October 2015
The clinical utility of aflibercept for diabetic macular edema
Stewart MW
Diabetes, Metabolic Syndrome and Obesity 2015, 8:473-482
Published Date: 18 September 2015
Bariatric surgery outcomes: a single-center study in the United Arab Emirates
Abusnana S, Abdi S, Tagure B, Elbagir M, Maleckas A
Diabetes, Metabolic Syndrome and Obesity 2015, 8:461-471
Published Date: 18 September 2015
Causes and consequences of obesity: epigenetics or hypokinesis?
Graham MR, Baker JS, Davies B
Diabetes, Metabolic Syndrome and Obesity 2015, 8:455-460
Published Date: 16 September 2015
An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting
Courtney MR, Moler EJ, Osborne JA, Whitney G, Conard SE
Diabetes, Metabolic Syndrome and Obesity 2015, 8:447-453
Published Date: 18 September 2015
Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A
Diabetes, Metabolic Syndrome and Obesity 2015, 8:437-445
Published Date: 15 September 2015
C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
Dongway AC, Faggad AS, Zaki HY, Abdalla BE
Diabetes, Metabolic Syndrome and Obesity 2015, 8:427-435
Published Date: 4 September 2015
Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management
Palimeri S, Palioura E, Diamanti-Kandarakis E
Diabetes, Metabolic Syndrome and Obesity 2015, 8:415-426
Published Date: 1 September 2015
Evaluation of the relationship between the pelvic floor muscles and insulin resistance
Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM
Diabetes, Metabolic Syndrome and Obesity 2015, 8:409-413
Published Date: 28 August 2015
Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice
Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB
Diabetes, Metabolic Syndrome and Obesity 2015, 8:399-407
Published Date: 26 August 2015
Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
Yang C, Loehn M, Jurczyk A, Przewozniak N, Leehy L, Herrera PL, Shultz LD, Greiner DL, Harlan DM, Bortell R
Diabetes, Metabolic Syndrome and Obesity 2015, 8:387-398
Published Date: 20 August 2015
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
Gurung T, Shyangdan DS, O’Hare JP, Waugh N
Diabetes, Metabolic Syndrome and Obesity 2015, 8:363-386
Published Date: 10 August 2015
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
Zheng X, Li S, Zhang WH, Yang H
Diabetes, Metabolic Syndrome and Obesity 2015, 8:357-361
Published Date: 5 August 2015
Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD
Diabetes, Metabolic Syndrome and Obesity 2015, 8:347-355
Published Date: 4 August 2015
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S
Diabetes, Metabolic Syndrome and Obesity 2015, 8:339-345
Published Date: 27 July 2015
The humanistic and economic burden associated with increasing body mass index in the EU5
Gupta S, Richard L, Forsythe A
Diabetes, Metabolic Syndrome and Obesity 2015, 8:327-338
Published Date: 22 July 2015
Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Yang F, Stewart M, Ye J, DeMets D
Diabetes, Metabolic Syndrome and Obesity 2015, 8:315-325
Published Date: 20 July 2015
Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
Penfornis A, Fiquet B, Blicklé JF, Dejager S
Diabetes, Metabolic Syndrome and Obesity 2015, 8:303-313
Published Date: 3 July 2015
Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome
Smith CJ, Ryckman KK
Diabetes, Metabolic Syndrome and Obesity 2015, 8:295-302
Published Date: 29 June 2015
Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
Fleming JW, Fleming LW, Davis CS
Diabetes, Metabolic Syndrome and Obesity 2015, 8:287-294
Published Date: 25 June 2015
Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
Evans M, Judy WV, Wilson D, Rumberger JA, Guthrie N
Diabetes, Metabolic Syndrome and Obesity 2015, 8:275-286
Published Date: 25 June 2015
Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions
McGrice M, Don Paul K
Diabetes, Metabolic Syndrome and Obesity 2015, 8:263-274
Published Date: 23 June 2015
Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
Raffaelli M, Sessa L, Mingrone G, Bellantone R
Diabetes, Metabolic Syndrome and Obesity 2015, 8:255-262
Published Date: 8 June 2015
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O
Diabetes, Metabolic Syndrome and Obesity 2015, 8:241-253
Published Date: 18 May 2015
Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu R, Shi H, Xue B, Zemel MB
Diabetes, Metabolic Syndrome and Obesity 2015, 8:227-239
Published Date: 6 May 2015
Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity 2015, 8:219-226
Published Date: 29 April 2015
Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study
Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA
Diabetes, Metabolic Syndrome and Obesity 2015, 8:213-218
Published Date: 23 April 2015
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Aziz KMA
Diabetes, Metabolic Syndrome and Obesity 2015, 8:207-211
Published Date: 16 April 2015
Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
Mohammed AE, Shenkute TY, Gebisa WC
Diabetes, Metabolic Syndrome and Obesity 2015, 8:197-206
Published Date: 15 April 2015
Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
Sosale A, Saboo B, Sosale B
Diabetes, Metabolic Syndrome and Obesity 2015, 8:189-196
Published Date: 15 April 2015
Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
Wu J, Yan LJ
Diabetes, Metabolic Syndrome and Obesity 2015, 8:181-188
Published Date: 2 April 2015
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
Petrella RJ, Gill DP, Berrou JP
Diabetes, Metabolic Syndrome and Obesity 2015, 8:173-180
Published Date: 24 March 2015
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
Nishio S, Abe M, Ito H
Diabetes, Metabolic Syndrome and Obesity 2015, 8:163-171
Published Date: 18 March 2015
Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients
Hitsumoto T, Shirai K
Diabetes, Metabolic Syndrome and Obesity 2015, 8:157-162
Published Date: 10 March 2015
Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial
Nagatomo A, Nishida N, Fukuhara I, Noro A, Kozai Y, Sato H, Matsuura Y
Diabetes, Metabolic Syndrome and Obesity 2015, 8:147-156
Published Date: 6 March 2015
Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N
Diabetes, Metabolic Syndrome and Obesity 2015, 8:137-145
Published Date: 2 March 2015
Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
Nitzan O, Elias M, Chazan B, Saliba W,
Diabetes, Metabolic Syndrome and Obesity 2015, 8:129-136
Published Date: 26 February 2015
Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A
Diabetes, Metabolic Syndrome and Obesity 2015, 8:121-127
Published Date: 26 February 2015
Effect of different exercise intensities on the pancreas of animals with metabolic syndrome
Amaral F, Lima NEA, Ornelas E, Simardi L, Fonseca FLA, Maifrino LBM
Diabetes, Metabolic Syndrome and Obesity 2015, 8:115-120
Published Date: 13 February 2015
Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
Tojo A, Hatakeyama S, Kinugasa S, Nangaku M
Diabetes, Metabolic Syndrome and Obesity 2015, 8:103-113
Published Date: 13 February 2015
Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
Mazzilli R, Imbrogno N, Elia J, Delfino M, Bitterman O, Napoli A, Mazzilli F
Diabetes, Metabolic Syndrome and Obesity 2015, 8:97-101
Published Date: 11 February 2015
Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
Di Pierro F, Bellone I, Rapacioli G, Putignano P
Diabetes, Metabolic Syndrome and Obesity 2015, 8:89-96
Published Date: 4 February 2015
GABAergic system in the endocrine pancreas: a new target for diabetes treatment
Wan Y, Wang Q, Prud’homme GJ
Diabetes, Metabolic Syndrome and Obesity 2015, 8:79-87
Published Date: 3 February 2015
The prevalence of adverse cardiometabolic responses to exercise training with evidence-based practice is low
Dalleck LC, Van Guilder GP, Richardson TB, Vella CA
Diabetes, Metabolic Syndrome and Obesity 2015, 8:73-78
Published Date: 29 January 2015
Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study
Abebe SM, Berhane Y, Worku A, Alemu S, Mesfin N
Diabetes, Metabolic Syndrome and Obesity 2015, 8:65-71
Published Date: 27 January 2015
Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study
Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA
Diabetes, Metabolic Syndrome and Obesity 2015, 8:57-63
Published Date: 23 January 2015
Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Kruger DF, LaRue S, Estepa P
Diabetes, Metabolic Syndrome and Obesity 2015, 8:49-56
Published Date: 16 January 2015
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
Kostev K, Dippel FW, Rathmann W
Diabetes, Metabolic Syndrome and Obesity 2015, 8:45-48
Published Date: 14 January 2015
Psychosocial interventions for the diabetic patient
Harvey JN
Diabetes, Metabolic Syndrome and Obesity 2015, 8:29-43
Published Date: 9 January 2015
Type 2 diabetes in Brazil: epidemiology and management
Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG
Diabetes, Metabolic Syndrome and Obesity 2015, 8:17-28
Published Date: 5 January 2015
Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children
Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F
Diabetes, Metabolic Syndrome and Obesity 2015, 8:9-15
Published Date: 17 December 2014
Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics
Takahashi PY, St Sauver JL, Finney Rutten LJ, Jacobson RM, Jacobson DJ, McGree ME, Ebbert JO
Diabetes, Metabolic Syndrome and Obesity 2015, 8:1-8
Published Date: 16 December 2014